Related Experiment Video
Updated: Jun 13, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Lipid membranes and beta-amyloid: a harmful connection
G P Eckert1, W G Wood, W E Müller
1Goethe-University of Frankfurt, Department of Pharmacology,Campus Riedberg, Biocenter N260 R1.09, Max-von-Laue Strasse 9, D-60438 Frankfurt, Germany. G.P.Eckert@em.uni-frankfurt.de
Alzheimer's disease (AD) may initiate in cell membranes. Beta-amyloid peptides (Abeta) disrupt membrane properties, potentially starting the neurotoxic cascade by interacting with lipids and altering calcium signaling.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alzheimer's disease (AD) pathogenesis is linked to the amyloid cascade hypothesis.
- Beta-amyloid peptides (Abeta) are central to AD, originating from amyloid precursor protein cleavage.
- The brain's membrane lipid environment may influence secretase activity and Abeta production.
Purpose of the Study:
- To review the role of cell membranes in initiating the neurotoxic cascade of Abeta.
- To examine the physico-chemical interactions between Abeta and membrane components.
- To explore Abeta's effects on membrane fluidity, lipid binding, and cellular calcium signaling.
Main Methods:
- Review of existing scientific literature on Abeta interactions with biological membranes.
- Analysis of studies investigating Abeta's effects on membrane properties (fluidity, integrity).
- Examination of research on Abeta's binding affinities to membrane lipids (cholesterol, phospholipids, gangliosides).
Main Results:
- Abeta peptides perturb artificial, isolated, and living cell membranes.
- Changes in membrane fluidity induced by Abeta are attributed to interactions with cholesterol, phospholipids, and gangliosides.
- Evidence suggests cell membranes are a key site for Abeta-initiated neurotoxicity.
Conclusions:
- Cell membranes are implicated as the initiation site for the Abeta-driven neurotoxic cascade in Alzheimer's disease.
- Abeta's interactions with membrane lipids and subsequent effects on membrane properties are critical.
- Further research into Abeta-membrane interactions could reveal novel therapeutic targets for AD.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Asymmetric Lipid Bilayer
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...

